+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 286 Pages
  • November 2024
  • Region: Global
  • GlobalData
  • ID: 5693564
The Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Auto-Immune Diseases pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Monitoring Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Monitoring Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Monitoring Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Auto-Immune Diseases Overview
3 Products under Development
3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development
3.2 Auto-Immune Diseases - Pipeline Products by Territory
3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path
3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
3.5 Auto-Immune Diseases - Ongoing Clinical Trials
4 Auto-Immune Diseases - Pipeline Products under Development by Companies
4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development
5 Auto-Immune Diseases Companies and Product Overview6 Auto-Immune Diseases- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Auto-Immune Diseases - Pipeline Products by Territory
  • Auto-Immune Diseases - Pipeline Products by Regulatory Path
  • Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
  • Auto-Immune Diseases - Ongoing Clinical Trials
  • Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
  • Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Auto-Immune Diseases - Pipeline Products by Stage of Development
  • Auto-Immune Diseases - Pipeline Products by Territory
  • Auto-Immune Diseases - Pipeline Products by Regulatory Path
  • Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
  • Auto-Immune Diseases - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aarhus University
  • Abreos Biosciences Inc
  • Adaptive Biotechnologies Corp
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Amarantus Diagnostics Inc
  • apDia nv
  • Asylia Diagnostics BV
  • Autoimmune Technologies LLC
  • Avotres Inc
  • Beckman Coulter Inc
  • Bellvitge Biomedical Research Institute
  • BG Medicine Inc
  • Biogen Inc
  • BIOHOPE Scientific SL
  • Biomedal SL
  • Bionure Farma SL (Inactive)
  • BioShai Ltd
  • Biotome Pty Ltd
  • CDI Laboratories Inc
  • Celdara Medical LLC
  • Charite University Hospital of Berlin
  • Chronix Biomedical Inc
  • Cincinnati Children's Hospital Medical Center
  • Cizzle Biotechnology Holdings Plc
  • Co-Diagnostics Inc
  • Columbia University
  • Crescendo Bioscience Inc
  • Department of Biomedical Engineering Columbia University
  • Digna Biotech SL
  • DNAlytics SA
  • Enterome Bioscience SA
  • Exagen Diagnostics Inc
  • Exodus Biosciences LLC
  • Ezose Sciences Inc.
  • Flamentera AG
  • Genalyte Inc
  • GeNeuro SA
  • Grifols SA
  • Guangzhou Wondfo Biotech Co Ltd
  • Hannover Medical School
  • HealthTell Inc
  • Helmholtz Centre for Infection Research
  • HOB Biotech Group Suzhou Co Ltd
  • Hospital for Special Surgery
  • HTG Molecular Diagnostics Inc
  • Hycor Biomedical Inc
  • Ignyta Inc
  • Immunarray Pvt Ltd
  • Immunovia AB
  • ImmusanT Inc
  • Innobiochips
  • Inova Diagnostics Inc
  • InterVenn BioSciences
  • Iron Horse Diagnostics, Inc.
  • JJP Biologics Sp Zoo
  • Johns Hopkins University
  • Lankenau Institute for Medical Research
  • LineaGen Inc
  • Lophius Biosciences GmbH
  • Louisville Bioscience Inc (Inactive)
  • Max Delbruck Center for Molecular Medicine
  • Mayo Clinic
  • Medica Corp
  • Medical & Biological Laboratories Co Ltd
  • Metabiomics Corporation
  • Metabolomic Technologies Inc
  • Metabolon Inc
  • Metanomics Health GmbH
  • MSDx Inc
  • Myriad Genetics Inc
  • Nanosphere Inc (Inactive)
  • Neuro Vigor LLC
  • NoToPharm srl
  • Numares AG
  • OmniBiome Therapeutics Inc
  • One Way Liver SL
  • OPKO Health Inc
  • Op-T-Mune Inc
  • Oxford Biodynamics Plc
  • Oxford Gene Technology Ltd
  • Oxford Immunotec Ltd
  • Pearsanta Inc
  • Pediatric Bioscience LLC
  • Penn State College of Medicine
  • Prediction BioSciences SAS
  • Progentec Diagnostics Inc
  • Prometheus Biosciences Inc
  • Protagen AG
  • ProteinLogic Ltd
  • Psyros Diagnostics Ltd
  • Quanterix Corp
  • Rambam Health Care Campus
  • Rappaport Family Institute for Research in the Medical Science
  • Revvity Inc
  • Roche Diagnostics
  • Roche Diagnostics International Ltd
  • Royal College of Surgeons Ireland
  • Scailyte AG
  • Seattle Children's Hospital
  • Sengenics Corp LLC
  • Sequenom Inc
  • Shuwen Biotech Co Ltd
  • SomaLogic Inc
  • Southern Illinois University Carbondale
  • Spanish National Research Council
  • SQI Diagnostics Inc
  • Statens Serum Institut
  • Sugentech Inc
  • Svar Life Science AB
  • TBG Diagnostics Ltd
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • Toscana Biomarkers Srl
  • University Health Network
  • University of Alberta
  • University of California Irvine
  • University of California San Francisco
  • University of Chicago
  • University of Colorado
  • University of Illinois at Chicago
  • University of Maryland Baltimore
  • University of Missouri
  • University of New South Wales
  • University of Oslo
  • University of Oxford
  • University of Pecs
  • US Biomarkers Inc
  • Veravas Inc
  • VolitionRX Ltd
  • Washington University in St Louis
  • WerfenLife SA
  • XEPTAGEN SpA
  • Yale University